These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38394643)

  • 1. Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney Disease.
    Li D; Hsu FC; Palmer ND; Liu L; Choi YA; Murea M; Parks JS; Bowden DW; Freedman BI; Ma L
    Diabetes; 2024 Jul; 73(7):1188-1195. PubMed ID: 38394643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analyses reveal lysosomal-associated protein transmembrane 5 as a potential therapeutic target in lipotoxicity-induced injury in diabetic kidney disease.
    Chen X; Zhu S; Huang C; Liu J; Wang J; Cui S
    Ren Fail; 2024 Dec; 46(2):2359638. PubMed ID: 38832484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease.
    Zhang X; Chao P; Zhang L; Xu L; Cui X; Wang S; Wusiman M; Jiang H; Lu C
    Front Immunol; 2023; 14():1030198. PubMed ID: 37063851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis of human diabetic kidney disease.
    Woroniecka KI; Park AS; Mohtat D; Thomas DB; Pullman JM; Susztak K
    Diabetes; 2011 Sep; 60(9):2354-69. PubMed ID: 21752957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach.
    Carlsson AC; Nowak C; Lind L; Östgren CJ; Nyström FH; Sundström J; Carrero JJ; Riserus U; Ingelsson E; Fall T; Ärnlöv J
    Ups J Med Sci; 2020 Feb; 125(1):37-43. PubMed ID: 31805809
    [No Abstract]   [Full Text] [Related]  

  • 6. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
    O'connor T; Ireland LS; Harrison DJ; Hayes JD
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression-based analysis identified NTNG1 and HGF as biomarkers for diabetic kidney disease.
    Tang YL; Dong XY; Zeng ZG; Feng Z
    Medicine (Baltimore); 2020 Jan; 99(1):e18596. PubMed ID: 31895808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
    Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
    PeerJ; 2022; 10():e13932. PubMed ID: 36157062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes for diabetic kidney disease using biological informatics methods.
    Ma F; Sun T; Wu M; Wang W; Xu Z
    Mol Med Rep; 2017 Dec; 16(6):7931-7938. PubMed ID: 28990106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of potential biomarkers for diabetic kidney disease based on single-cell RNA-sequencing integrated with a single-cell sequencing assay for transposase-accessible chromatin.
    Shi Y; Guo Z; Liu F; Pan S; Gao D; Zhou S; Liu Z; Wang F; Liu D; Liu Z
    Aging (Albany NY); 2023 Oct; 15(19):10681-10704. PubMed ID: 37827693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.
    Sandholm N; Cole JB; Nair V; Sheng X; Liu H; Ahlqvist E; van Zuydam N; Dahlström EH; Fermin D; Smyth LJ; Salem RM; Forsblom C; Valo E; Harjutsalo V; Brennan EP; McKay GJ; Andrews D; Doyle R; Looker HC; Nelson RG; Palmer C; McKnight AJ; Godson C; Maxwell AP; Groop L; McCarthy MI; Kretzler M; Susztak K; Hirschhorn JN; Florez JC; Groop PH;
    Diabetologia; 2022 Sep; 65(9):1495-1509. PubMed ID: 35763030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased secretion and profibrotic activity of tubular exosomes in diabetic kidney disease.
    Wen J; Ma Z; Livingston MJ; Zhang W; Yuan Y; Guo C; Liu Y; Fu P; Dong Z
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F664-F673. PubMed ID: 32715764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
    Huang B; Wen W; Ye S
    Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbiased Human Kidney Tissue Proteomics Identifies Matrix Metalloproteinase 7 as a Kidney Disease Biomarker.
    Hirohama D; Abedini A; Moon S; Surapaneni A; Dillon ST; Vassalotti A; Liu H; Doke T; Martinez V; Md Dom Z; Karihaloo A; Palmer MB; Coresh J; Grams ME; Niewczas MA; Susztak K
    J Am Soc Nephrol; 2023 Jul; 34(7):1279-1291. PubMed ID: 37022120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease.
    Wang M; Wang J; Wang J; Wu Y; Qi X
    Ren Fail; 2024 Dec; 46(1):2313182. PubMed ID: 38345057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiomics Analyses Reveal Sex Differences in Mouse Renal Proximal Subsegments.
    Chen L; Chou CL; Yang CR; Knepper MA
    J Am Soc Nephrol; 2023 May; 34(5):829-845. PubMed ID: 36758122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxymethylcytosine profiles in plasma cell-free DNA reflect molecular characteristics of diabetic kidney disease.
    Chu JL; Bi SH; He Y; Ma RY; Wan XY; Wang ZH; Zhang L; Zheng MZ; Yang ZQ; Du LW; Maimaiti Y; Biekedawulaiti G; Duolikun M; Chen HY; Chen L; Li LL; Tie L; Lin J
    Front Endocrinol (Lausanne); 2022; 13():910907. PubMed ID: 35966076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Protein Translation and Carboxylic Acid Catabolic Processes in Diabetic Kidney Disease.
    Collins KS; Eadon MT; Cheng YH; Barwinska D; Melo Ferreira R; McCarthy TW; Janosevic D; Syed F; Maier B; El-Achkar TM; Kelly KJ; Phillips CL; Hato T; Sutton TA; Dagher PC
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes in diabetic kidney disease via multiple-microarray analysis.
    Zhang Y; Li W; Zhou Y
    Ann Transl Med; 2020 Aug; 8(16):997. PubMed ID: 32953797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenine crosses the biomarker bridge: from 'omics to treatment in diabetic kidney disease.
    Drexler Y; Fornoni A
    J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37843281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.